Drugplain

HYPERRAB S/D 150 [iU]/mL

RABIES IMMUNE GLOBULIN (HUMAN) · INJECTION · GRIFOLS USA, LLC

No Recall History
Plain English

HYPERRAB S/D is a injection containing rabies immune globulin (human) at 150 [iU]/mL, taken intramuscular. Manufactured by GRIFOLS USA, LLC.

Key Facts

Brand Name
HYPERRAB S/D
Generic Name
RABIES IMMUNE GLOBULIN (HUMAN)
NDC Code (Product)
13533-618
Manufacturer
GRIFOLS USA, LLC
Strength
150 [iU]/mL
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Marketing Status
Application #
BLA101144
Marketing Start
08/14/1996

Recall History

No Recall History

Frequently Asked Questions

What is HYPERRAB S/D used for?

HYPERRAB S/D contains RABIES IMMUNE GLOBULIN (HUMAN). It is a injection taken intramuscular. Consult your doctor for specific uses.

Is HYPERRAB S/D a controlled substance?

HYPERRAB S/D is not classified as a controlled substance by the DEA.

What is the generic name for HYPERRAB S/D?

The generic name for HYPERRAB S/D is RABIES IMMUNE GLOBULIN (HUMAN). There are 1 other brand versions of RABIES IMMUNE GLOBULIN (HUMAN).

What is the NDC code for HYPERRAB S/D 150 [iU]/mL?

The NDC (National Drug Code) for HYPERRAB S/D 150 [iU]/mL is 13533-618, listed by GRIFOLS USA, LLC.

Product NDC

13533-618

Package NDC

13533-618-02

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)